ENTRY       D10832            Mixture   Drug
NAME        Darunavir and cobicistat;
            Prezcobix (TN);
            Rezolsta (TN)
  ABBR      DRV/c
PRODUCT     PREZCOBIX (A-S Medication Solutions)
            PREZCOBIX (Janssen Products LP)
COMPONENT   (Darunavir ethanolate [DR:D06478] | Darunavir [DR:D03656]), Cobicistat [DR:D09881]
CLASS       Antiviral
             DG03107  Anti-HIV agent
REMARK      Therapeutic category: 6250
            ATC code: J05AR14
            Product: D10832<JP/US>
EFFICACY    Antiviral
  DISEASE   HIV-1 infection [DS:H01563]
TARGET      HIV protease [KO:K22599]
  PATHWAY   ko03230(K22599)  Viral genome structure
            ko03250(K22599)  Viral life cycle - HIV-1
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J05 ANTIVIRALS FOR SYSTEMIC USE
               J05A DIRECT ACTING ANTIVIRALS
                J05AR Antivirals for treatment of HIV infections, combinations
                 J05AR14 Darunavir and cobicistat
                  D10832  Darunavir and cobicistat &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antivirals
              Anti-HIV Combinations
               Darunavir/ Cobicistat
                D10832  Darunavir and cobicistat
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              62  Chemotherapeutics
               625  Antivirals
                6250  Antivirals
                 D10832  Darunavir and cobicistat
            Drug groups [BR:br08330]
             Antiviral
              DG03107  Anti-HIV agent
               D10832  Darunavir and cobicistat
            Drug classes [BR:br08332]
             Antiviral
              DG03107  Anti-HIV agent
               D10832  Darunavir and cobicistat
            Antimicrobials [BR:br08307]
             Antivirals
              Polyprotein cleavage inhibitor
               HIV protease inhibitor
                D10832  Darunavir and cobicistat &lt;JP/US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10832
DBLINKS     PubChem: 319902632
///
